BRAF and ameloblastoma: Recent advances of molecular biology unraveled that recurrent BRAF(V600E) activating mutation is the most common genetic aberration in ameloblastomas [3,4,5], however, the detailed tumorigenic molecular mechanism is yet to be fully elucidated.